IV 
117TH CONGRESS 
2D SESSION 
H. RES. 1069 
Expressing support for the designation of May 7 each year as ‘‘Brain 
Donation Awareness Day’’. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 28, 2022 
Mr. BLUMENAUER (for himself and Mr. FITZPATRICK) submitted the following 
resolution; which was referred to the Committee on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of May 7 each year 
as ‘‘Brain Donation Awareness Day’’. 
Whereas 100,000,000 Americans are currently living with 
disabling and debilitating brain disorders; 
Whereas an additional 1,200,000 people aged 18 years and 
older are diagnosed annually with adult onset brain dis-
ease or disorders in the United States; 
Whereas brain disease has a tremendous impact on individ-
uals, families, and society; 
Whereas there is a critical need to improve the understanding 
of 
what 
causes 
neurological 
diseases, 
including 
neurodegenerative, neurodevelopmental, and psychiatric 
disorders, to develop new approaches for prevention and 
treatment; 
VerDate Sep 11 2014 
23:35 Apr 28, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1069.IH
HR1069
kjohnson on DSK79L0C42PROD with BILLS
•HRES 1069 IH 
Whereas neurological conditions impact Americans of all 
ages, but the risk of neurodegenerative diseases increases 
dramatically with age; 
Whereas Americans are living longer than ever; therefore, 
more people will be affected by neurodegenerative dis-
eases in coming decades; 
Whereas, in 2021, 6,200,000 Americans were estimated to be 
living with Alzheimer’s disease; 
Whereas an estimated 1,200,000 people in the United States 
could be living with Parkinson’s disease by 2030; 
Whereas about 1 in 6 children in the United States has 1 or 
more developmental disabilities or other developmental 
delays; 
Whereas serious mental illness is rising, with over 47,000,000 
Americans experiencing a mental illness in 2021; 
Whereas 73,800,000 adults aged 18 or older in the United 
States reported having a mental health or substance 
abuse disorder in 2020; 
Whereas the underlying causes of most neurological condi-
tions remain largely unknown due to the vast complexity 
of the human brain; 
Whereas through research, the underlying causes of a greater 
number of neurological conditions can be understood; 
Whereas the Food and Drug Administration (FDA) and the 
National Institutes of Health (NIH) support research on 
new ways to treat, cure, and prevent neurological condi-
tions; 
Whereas the Director of the Center for Drug Evaluation and 
Research of the FDA testified before Congress in 2021 
VerDate Sep 11 2014 
23:35 Apr 28, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1069.IH
HR1069
kjohnson on DSK79L0C42PROD with BILLS
•HRES 1069 IH 
that the field of neuroscience requires more research to 
develop new, safe, and effective treatments; 
Whereas the NIH and institutes within the NIH launched the 
Brain 
Research 
Through 
Advancing 
Innovative 
Neurotechnologies® (BRAIN) Initiative in 2013 and con-
tinue to partner with a number of Federal agencies and 
private sector partners on the BRAIN Initiative; 
Whereas the NIH-funded NeuroBioBank was established in 
September 2013 as a national resource for investigators 
utilizing human post mortem brain tissue and related bio-
specimens for their research to understand conditions of 
the nervous system; 
Whereas post mortem brain tissue is an irreplaceable re-
source in brain research; 
Whereas there is a critical need to increase the availability 
of human diseased and control brains and related bio-
specimens; 
Whereas 1 brain can provide tissue for dozens, even hun-
dreds, of neurological studies; 
Whereas communities of color and poverty are underrep-
resented and understudied in neurological research; 
Whereas racial and socioeconomic diversity is paramount 
among brain donors so that research can investigate how 
and why neurological diseases and disorders dispropor-
tionately affect minority and low-income communities; 
Whereas through awareness, the public can be educated on 
how brain donation for neuroscience research is not a 
routine part of organ donation or anatomical body dona-
tion; 
VerDate Sep 11 2014 
23:35 Apr 28, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR1069.IH
HR1069
kjohnson on DSK79L0C42PROD with BILLS
•HRES 1069 IH 
Whereas the Brain Donor Project and the American Brain 
Coalition sponsor ‘‘Brain Donation Awareness Day’’ in 
the United States and partner with many other organiza-
tions to increase public awareness of neurological condi-
tions and the importance of brain research; and 
Whereas ‘‘Brain Donation Awareness Day’’ is expected to be 
observed in the United States for years to come, pro-
viding hope and information for patients, caregivers, and 
families around the country: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of ‘‘Brain Dona-
tion Awareness Day’’; and 
(2) recognizes the importance of, with respect 
to neurological conditions and disorders— 
(A) improving awareness; 
(B) research; 
(C) supporting national efforts to develop 
effective treatments, diagnostics, and cures; 
(D) supporting national efforts to address 
the urgent need for post mortem brain tissue, 
both control and diseased; and 
(E) educating on the importance of brain 
donation to support national research efforts. 
Æ 
VerDate Sep 11 2014 
23:35 Apr 28, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR1069.IH
HR1069
kjohnson on DSK79L0C42PROD with BILLS